シンバイオ製薬(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4582/E24682-
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2017/04/14日証協無担保0株0%0株0%865,543株+1.38%
2017/04/14日証協有担保4,071,900株-0.23%788,300株+1.36%1,798,700株-0.99%
2017/04/07日証協無担保0株0%0株0%853,743株+8.44%
2017/04/07日証協有担保4,081,400株+6.15%777,700株+36.46%1,816,700株+0.69%
2017/03/31日証協無担保0株0%0株0%787,300株-4.23%
2017/03/31日証協有担保3,845,000株-1.94%569,900株+6.11%1,804,200株-1.98%
2017/03/24日証協無担保0株0%0株0%822,046株+0.98%
2017/03/24日証協有担保3,921,100株-1.43%537,100株-0.54%1,840,600株-3.27%
2017/03/17日証協無担保0株0%0株0%814,088株-1.58%
2017/03/17日証協有担保3,977,800株-1.65%540,000株-4.66%1,902,900株-1.43%
2017/03/10日証協無担保0株0%0株0%827,188株-0.49%
2017/03/10日証協有担保4,044,500株-8.25%566,400株+9.51%1,930,600株-6.13%
2017/03/03日証協無担保0株0%0株0%831,288株+1.58%
2017/03/03日証協有担保4,408,000株-0.54%517,200株+65.19%2,056,700株+0.66%
2017/02/24日証協無担保0株0%0株0%818,388株+0.69%
2017/02/24日証協有担保4,431,800株+3.59%313,100株-33.03%2,043,200株+1.07%
2017/02/17日証協無担保0株0%0株0%812,788株+3.98%
2017/02/17日証協有担保4,278,100株-9.98%467,500株+12.54%2,021,500株-11.11%
2017/02/10日証協無担保0株0%0株0%781,688株+5.96%
2017/02/10日証協有担保4,752,400株-5.91%415,400株+31.41%2,274,100株-8.29%
2017/02/03日証協無担保0株0%0株0%737,688株+1.01%
2017/02/03日証協有担保5,050,700株-0.16%316,100株-15.89%2,479,700株-0.03%
2017/01/27日証協無担保0株0%0株0%730,288株+0.04%
2017/01/27日証協有担保5,059,000株+7.18%375,800株+4.62%2,480,400株+7.28%
2017/01/20日証協無担保0株0%0株0%729,988株-0.83%
2017/01/20日証協有担保4,720,200株+4.79%359,200株-7.47%2,312,100株+5.05%
2017/01/13日証協無担保0株0%0株0%736,129株+0.79%
2017/01/13日証協有担保4,504,500株-3.3%388,200株+10.95%2,200,900株-4.18%
2017/01/06日証協無担保0株0%0株0%730,329株+6.26%
2017/01/06日証協有担保4,658,400株-4.24%349,900株-10.67%2,296,800株-2.04%
2016/12/30日証協無担保0株0%0株0%687,300株-8.71%
2016/12/30日証協有担保4,864,800株+3.6%391,700株-23.32%2,344,700株+5.3%
2016/12/22日証協無担保0株0%0株0%752,888株-5.2%
2016/12/22日証協有担保4,695,700株-4.69%510,800株+20.87%2,226,600株-6.7%
2016/12/16日証協無担保0株-100%0株0%794,188株-1.48%
2016/12/16日証協有担保4,926,900株-0.68%422,600株-39.31%2,386,500株+3.48%
2016/12/09日証協無担保27,500株0%0株0%806,089株-0.73%
2016/12/09日証協有担保4,960,500株+0.2%696,300株-18.17%2,306,300株+4.99%

※株式分割は考慮していませんのでご注意ください。

Page Top